fda warning letters compounded glp-1 september 2025 30 telehealth companies received U.S. Food and Drug Administration for falsely marketing products online. said these companies claimed that their products are similar to generic FDA- approved products U.S. Food & Drug Administration

Tirzepatide Tirzepatide, the active ingredient in the brand-name injectable GLP-1 medications Mounjaro and Zepbound, starts at 2.5 mg weekly and can be increased to 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg

Conclusion GLP-1 RAs are an important class of glucose-lowering drugs

Common side effects include mild to moderate GI symptoms, but more serious health risks or complications may also occur in certain groups of people

They also support healthy blood sugar levels, which can further aid in weight management

Yet the substantia nigra dopaminergic neuron is also a metabolically stressed cell type whose autonomous activity, calcium handling, and large axonal arbor place unusual demands on linked purposeful movement, reinforcement, and cellular energetic support becomes progressively unstable

The food noise that is dampened while on GLP-1s likely returns after stopping use, increasing the importance of dietary levers to induce satiety